Myungin Pharm Pre-IPO: Domestic Leader, Partial Monetization for Founders
Myungin Pharm is looking to raise up to US$142m in its upcoming Korean IPO. In this note, we provide updates on the firm’s past performance.
394 Views
Myungin Pharmaceutical IPO Valuation Analysis
Our base case valuation of Myungin Pharm is target price of 80,349 won per share, which is 39% higher than the high end of the IPO price range.
1.7k Views
Myungin Pharmaceutical IPO Preview
Myungin Pharmaceutical is getting ready to complete its IPO in KOSPI in September. The IPO price range is from 45,000 won to 58,000 won.
482 Views